<!DOCTYPE html>
<html lang="en">
<head>
<meta charset="utf-8">
<meta name="viewport" content="width=device-width,initial-scale=1">
<title>glycerophospholipids causes colorectal cancer — pCite</title>
<link rel="stylesheet" href="../css/style.css">
</head>
<body>
<header>
  <h1><a href="../index.html">pCite</a></h1>
  <nav><a href="../index.html">Search</a><a href="../corpus.html">Corpus</a></nav>
</header>

<p class="section-label">CLAIM</p>
<hr class="section-rule">
<div class="triple">
  <strong>glycerophospholipids</strong>
  <span class="pred">&mdash;causes&rarr;</span>
  <strong>colorectal cancer</strong>
</div>
<div class="entity-id">CHEBI:37739 &nbsp;&middot;&nbsp; MESH:D015179</div>

<p class="section-label">VALIDATION</p>
<hr class="section-rule">
<div class="val-bar" style="--pct:5%;--color:#f0a030"></div>
<div class="stat-row">
  <span>Class: DB Referenced (0.5)</span>
  <span>Replicated: 1 paper</span>
  <span>Score: 4.56<span class="score-tip"><span class="tip-icon">&nbsp;&#9432;</span><span class="tip-text">Score = &Sigma; incoming citation weights. Each citation is weighted by the validation class of the source claim (Physical 10.0 &middot; DB Ref 0.5 &middot; Text Derived 0.01) multiplied by the citation type (Replicates 1.5 &middot; Supports 1.0 &middot; Contradicts &minus;0.5). A score of 364 means this claim received strong physical-tier citation support.</span></span></span>
</div>

<p class="section-label">SCORE BREAKDOWN</p>
<hr class="section-rule">
<div class="score-breakdown">Base weight: 0.50 (DB Referenced, 1 paper)<br>Score from 54 citations: <strong>4.56</strong><br><span style="color:#888">11&times; extends (+13.55) &middot; 9&times; supports (+4.50) &middot; 34&times; contradicts (-13.49)</span><br>Neighbourhood: 8.97</div>


<p class="section-label">EVIDENCE CHAIN &middot; 1 source</p>
<hr class="section-rule">
<div class="evidence-row"><span class="evidence-dot" style="background:#f0a030" title="DB Referenced"></span><span>DB Referenced</span><a href="https://doi.org/10.1002/ijc.31341">10.1002/ijc.31341</a></div>


<p class="section-label">CITATIONS RECEIVED &middot; 54 total</p>
<hr class="section-rule">
<div class="cite-bar"><span style="width:70px;text-align:right">Replicates</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Supports</span><span class="cite-bar-fill" style="width:26px"></span><span>9</span><span class="cite-subtotal">&middot; +4.50</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,3,4-trimethylhexane — is_metabolite_of → lipid peroxidation</span><span class="cite-claim-weight">+0.50</span><a href="../claim/a3d48c01fcd3dfbf.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,4-dimethylhept-1-ene — is_metabolite_of → lipid peroxidation</span><span class="cite-claim-weight">+0.50</span><a href="../claim/8b2a38e165b645fb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — causes → autophagy</span><span class="cite-claim-weight">+0.50</span><a href="../claim/0f54af221d4f8929.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — decreases → glycerophospholipid metabolism</span><span class="cite-claim-weight">+0.50</span><a href="../claim/3ead9219d29e702c.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lipid panel (PC 44:5 + PC 35:6e + SM d40:3) — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.50</span><a href="../claim/7c0a44eef9f07abe.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Serum metabolite panel (random forest model) — distinguishes → Advanced Adenoma / Colorectal Cancer vs NC/NAA</span><span class="cite-claim-weight">+0.50</span><a href="../claim/62876bbe01a7c696.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Serum metabolites (33 differential) — distinguishes → Advanced Adenoma vs Non-Advanced Adenoma</span><span class="cite-claim-weight">+0.50</span><a href="../claim/5b9b3587fa157624.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sphingolipid metabolism — is_biomarker_for → Colorectal adenoma progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/b346e1df6cfc5ffd.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Caffeine metabolism — is_biomarker_for → Colorectal adenoma progression</span><span class="cite-claim-weight">+0.50</span><a href="../claim/86361b6ef72179ae.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Contradicts</span><span class="cite-bar-fill" style="width:100px"></span><span>34</span><span class="cite-subtotal">&middot; -13.49</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">ceramides — is_biomarker_for → colorectal adenocarcinoma tissue</span><span class="cite-claim-weight">-2.32</span><a href="../claim/fbddabef2bccbbf8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Phosphatidylcholines (PCs) — is_biomarker_for → Colorectal Carcinoma</span><span class="cite-claim-weight">-2.00</span><a href="../claim/4d490d6332335a4a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Kynurenine — is_biomarker_for → Colorectal cancer stage</span><span class="cite-claim-weight">-0.65</span><a href="../claim/15709a5e8bd22547.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">tryptophan — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">-0.58</span><a href="../claim/a42864072a5c69c5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">bile acids — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">-0.40</span><a href="../claim/4013d9365dfef12a.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">plasma metabolites — distinguishes → colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/25bc564792710f83.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">metabolite peak count (VOC richness) — distinguishes → colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/036d3a84ec387294.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">VOC profile — distinguishes → colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/772e5e5d5e7e31c1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,3,4-trimethylhexane — decreases → colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/c156b7aeb268bbfa.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,3,4-trimethylhexane — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/e3304c000f3be0a4.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,4-dimethylhept-1-ene — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/74ad2fb01fce147d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — inhibits → HT-29 cell proliferation</span><span class="cite-claim-weight">-0.25</span><a href="../claim/31766c7322f98355.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — causes → apoptosis</span><span class="cite-claim-weight">-0.25</span><a href="../claim/f450cb5afb086188.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — causes → cell-cycle arrest</span><span class="cite-claim-weight">-0.25</span><a href="../claim/81fccc59511669d8.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — decreases → differentially expressed genes</span><span class="cite-claim-weight">-0.25</span><a href="../claim/238b7e488fac5456.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — decreases → differentially expressed metabolites</span><span class="cite-claim-weight">-0.25</span><a href="../claim/265300925280518e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — decreases → glutathione metabolism</span><span class="cite-claim-weight">-0.25</span><a href="../claim/64499e095d56f314.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">(-)-Epigallocatechin-3-gallate — treats → colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/3a88c882e6daeaf5.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Blood-derived mRNA biomarker panel — distinguishes → Colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/30be723bcb12245e.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Blood-derived microRNA biomarker panel — distinguishes → Colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/6a6e27e695168898.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Autoantibody biomarker panel — distinguishes → Colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/298d7d9229723def.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Blood metabolite biomarker panel — distinguishes → Colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/0d43bf1bbe1d4f31.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lysophosphatidylcholine (LysoPC) — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">-0.40</span><a href="../claim/da12e4ff94bff4d9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylglycerol — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/5ccf3ca6907853fc.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Sterol esters — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/2ddf49d0d1512692.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC 44:5 — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/30c5fd9ccfe505fb.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC 35:6e — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/8ddc19efefc1659b.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">SM d40:3 — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/8e4961dd3a493b4d.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sphingomyelin — is_biomarker_for → colorectal advanced adenoma</span><span class="cite-claim-weight">-0.25</span><a href="../claim/4e8c3e1d7977e813.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">sphingomyelin — is_biomarker_for → colorectal cancer</span><span class="cite-claim-weight">-0.40</span><a href="../claim/bdaabbf0139a1174.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Serum metabolite composition — distinguishes → Colorectal cancer vs Healthy controls / Non-Advanced Adenoma</span><span class="cite-claim-weight">-0.25</span><a href="../claim/2963ed71769b9647.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">LASSO-selected serum metabolites (57 variables) — distinguishes → Advanced Adenoma / CRC vs NC / Non-Advanced Adenoma</span><span class="cite-claim-weight">-0.25</span><a href="../claim/dcd91957516ba626.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">gut microbiome bacterial taxa — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/805610d08bb2c132.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">gut metabolites — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">-0.25</span><a href="../claim/436e82b469d0c090.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Extends</span><span class="cite-bar-fill" style="width:32px"></span><span>11</span><span class="cite-subtotal">&middot; +13.55</span></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#ff7f0e"></span><span class="cite-claim-triple">Fatty acids — is_biomarker_for → Colorectal Cancer</span><span class="cite-claim-weight">+7.20</span><a href="../claim/6ad1651b9e44eeed.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine (PC 16:0/18:1) — distinguishes → pMMR vs dMMR colorectal cancer</span><span class="cite-claim-weight">+0.95</span><a href="../claim/7cd9963dbde9d220.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">2,4-dimethylhept-1-ene — increases → colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/acb7845754617579.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PC(18:0/18:1) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/8477d23a810774c9.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">PE(18:0/20:4) — distinguishes → Colorectal Cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/bb50e0c283aa54f1.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylcholine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.60</span><a href="../claim/bb313c103d3f8b81.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Phosphatidylethanolamine — increases → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.60</span><a href="../claim/367abe64d5d037b2.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Lipogenic phenotype (upregulated lipogenesis) — correlates_with → Colorectal Cancer tumor progression</span><span class="cite-claim-weight">+0.60</span><a href="../claim/fc1a0b488fe38bb6.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">phosphatidylcholine — is_biomarker_for → colorectal advanced adenoma</span><span class="cite-claim-weight">+0.60</span><a href="../claim/735d077b4e121736.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">differential lipids (top 10) — distinguishes → colorectal advanced adenoma vs colorectal cancer</span><span class="cite-claim-weight">+0.60</span><a href="../claim/d90eba95077dd648.html">view &rarr;</a></div>
<div class="cite-claim"><span class="evidence-dot" style="background:#f0a030"></span><span class="cite-claim-triple">Glycerophospholipid metabolism — is_biomarker_for → Colorectal adenoma progression</span><span class="cite-claim-weight">+0.60</span><a href="../claim/c20a2c04aee99d51.html">view &rarr;</a></div>
<div class="cite-bar"><span style="width:70px;text-align:right">Applies</span><span class="cite-bar-fill" style="width:0px"></span><span>0</span></div>


<p class="section-label">IDENTIFIERS</p>
<hr class="section-rule">
<table class="id-table">
<tr><td>Claim ID</td><td><code>95b626a1b17019f3</code></td></tr>
<tr><td>Subject URI</td><td><a href="https://identifiers.org/CHEBI:37739">CHEBI:37739</a></td></tr>
<tr><td>Object URI</td><td><a href="https://identifiers.org/MESH:D015179">MESH:D015179</a></td></tr>
</table>
<footer>pCite — validation-weighted scientific claims</footer>
</body>
</html>
